Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.080 EUR
12.45 M EUR
192.51 M EUR
52.19 M
About Gaush Meditech Ltd.
Sector
Industry
CEO
Xin Wei Liu
Website
Headquarters
Beijing
Founded
2017
ISIN
KYG3902N1051
FIGI
BBG01GL5MC70
Gaush Meditech Ltd. is an investment holding company, which engages in the provision of ophthalmic medical devices. It operates through the following segments: Proprietary Products, Distribution, Technical Services, and Others. The Proprietary Products segment develops and produces surgical equipment and related supporting software, intra optical lens, ophthalmic disease diagnosis and treatment equipment and related supporting consumables independently. The Distribution segment sells comprehensive diagnostic equipment, ocular fundus diagnosis, surgical and treatment equipment and related supporting consumables. The Technical Services segment provides warranty services, maintenance services and after-sales services. The Others segment covers equipment leasing services and the agent registration services to certain customers. The company was founded by Tie Ta Gao on November 1, 2017 and is headquartered in Beijing, China.
Related stocks
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange Gaush Meditech Ltd. stocks are traded under the ticker F7Y.
Yes, you can track Gaush Meditech Ltd. financials in yearly and quarterly reports right on TradingView.
Gaush Meditech Ltd. is going to release the next earnings report on Apr 1, 2026. Keep track of upcoming events with our Earnings Calendar.
F7Y net income for the last half-year is 4.41 M EUR, while the previous report showed 8.62 M EUR of net income which accounts for −48.84% change. Track more Gaush Meditech Ltd. financial stats to get the full picture.
Yes, F7Y dividends are paid annually. The last dividend per share was 0.03 EUR. As of today, Dividend Yield (TTM)% is 3.65%. Tracking Gaush Meditech Ltd. dividends might help you take more informed decisions.
Gaush Meditech Ltd. dividend yield was 3.05% in 2024, and payout ratio reached 44.27%. The year before the numbers were 2.91% and 84.89% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 4, 2025, the company has 884 employees. See our rating of the largest employees — is Gaush Meditech Ltd. on this list?
Like other stocks, F7Y shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Gaush Meditech Ltd. stock right from TradingView charts — choose your broker and connect to your account.